Wu W, Yu N, Chen W, Zhu Y
Epigenetics. 2024; 19(1):2435682.
PMID: 39612365
PMC: 11610569.
DOI: 10.1080/15592294.2024.2435682.
Suri C, Pande B, Suhasini Sahithi L, Sahu T, Verma H
Microorganisms. 2024; 12(10).
PMID: 39458339
PMC: 11510474.
DOI: 10.3390/microorganisms12102030.
Chen Y, Lee Y, Lee C, Lin T, Hwu E, Cheng P
PLoS Negl Trop Dis. 2024; 18(9):e0012502.
PMID: 39264964
PMC: 11421824.
DOI: 10.1371/journal.pntd.0012502.
Wei Q, Gan C, Sun M, Xie Y, Liu H, Xue T
Biomark Res. 2024; 12(1):92.
PMID: 39215370
PMC: 11365212.
DOI: 10.1186/s40364-024-00641-6.
Zhang M, Wu X, Zhu H, Fu C, Yang W, Jing X
Biochem Genet. 2024; .
PMID: 38871957
DOI: 10.1007/s10528-024-10853-y.
lncRNA-mRNA Co-Expression and Regulation Analysis in Lung Fibroblasts from Idiopathic Pulmonary Fibrosis.
Lopez-Martinez A, Santos-Alvarez J, Velazquez-Enriquez J, Ramirez-Hernandez A, Vasquez-Garzon V, Baltierrez-Hoyos R
Noncoding RNA. 2024; 10(2).
PMID: 38668384
PMC: 11054336.
DOI: 10.3390/ncrna10020026.
Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis.
Elek A, Bozgeyik E, Caska H, Gocer Z, Bozgeyik I
Ir J Med Sci. 2024; 193(4):1923-1927.
PMID: 38523167
DOI: 10.1007/s11845-024-03675-9.
CSE regulates LINC000665/XBP-1 in the progress of pulmonary fibrosis.
Song M, Shen Q, Ouyang X, Zhou Z, Luo H, Peng H
Tob Induc Dis. 2023; 21:170.
PMID: 38111802
PMC: 10726211.
DOI: 10.18332/tid/175004.
[Biomechanical properties of epithelial mesenchymal transition in idiopathic pulmonary fibrosis].
Li M, Sun M, Jia Y, Ren H, Liu H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023; 40(4):632-637.
PMID: 37666752
PMC: 10477379.
DOI: 10.7507/1001-5515.202206016.
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro.
Cucinotta L, Mannino D, Casili G, Repici A, Crupi L, Paterniti I
Respir Res. 2023; 24(1):211.
PMID: 37626373
PMC: 10463606.
DOI: 10.1186/s12931-023-02519-x.
Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone.
Abdalhameid E, Abd El-Haleim E, Abdelsalam R, Georgy G, Fawzy H, Kenawy S
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(2):1071-1079.
PMID: 37581637
PMC: 10791841.
DOI: 10.1007/s00210-023-02652-w.
Properties of Pleural Mesothelial Cells in Idiopathic Pulmonary Fibrosis and Cryptogenic Organizing Pneumonia.
Loloci G, Kim Y, Choi W, Jang H, Park S, Kwon K
J Korean Med Sci. 2023; 38(31):e242.
PMID: 37550810
PMC: 10412035.
DOI: 10.3346/jkms.2023.38.e242.
-Derived Extracellular Vesicles Attenuate Bleomycin-Induced Pulmonary Fibrosis Trough Antioxidant, Anti-Inflammatory and Protease Activity in a Mouse Model.
Ramirez-Hernandez A, Reyes-Jimenez E, Velazquez-Enriquez J, Santos-Alvarez J, Soto-Guzman A, Castro-Sanchez L
Cells. 2023; 12(14).
PMID: 37508515
PMC: 10378408.
DOI: 10.3390/cells12141852.
Regulatory Cues in Pulmonary Fibrosis-With Emphasis on the AIM2 Inflammasome.
Tseng Y, Chen I, Li W, Hsu J
Int J Mol Sci. 2023; 24(13).
PMID: 37446052
PMC: 10341703.
DOI: 10.3390/ijms241310876.
Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis.
Li H, Wang W, Huang Z, Zhang P, Liu L, Sha X
J Thorac Dis. 2023; 15(6):3054-3068.
PMID: 37426132
PMC: 10323588.
DOI: 10.21037/jtd-22-1522.
Fendrr synergizes with Wnt signalling to regulate fibrosis related genes during lung development via its RNA:dsDNA triplex element.
Ali T, Rogala S, Krause N, Bains J, Melissari M, Wahrisch S
Nucleic Acids Res. 2023; 51(12):6227-6237.
PMID: 37207329
PMC: 10325902.
DOI: 10.1093/nar/gkad395.
LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway.
Qi F, Lv Z, Huang W, Wei S, Liu X, Song W
Epigenetics. 2023; 18(1):2195305.
PMID: 36994860
PMC: 10072061.
DOI: 10.1080/15592294.2023.2195305.
Quantitative Proteomic Characterization of Foreign Body Response towards Silicone Breast Implants Identifies Chronological Disease-Relevant Biomarker Dynamics.
Schoberleitner I, Faserl K, Sarg B, Egle D, Brunner C, Wolfram D
Biomolecules. 2023; 13(2).
PMID: 36830674
PMC: 9953687.
DOI: 10.3390/biom13020305.
Idiopathic Pulmonary Fibrosis and Telomeres.
Mulet A, Signes-Costa J
J Clin Med. 2022; 11(23).
PMID: 36498467
PMC: 9740997.
DOI: 10.3390/jcm11236893.
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.
Antar S, Saleh M, Al-Karmalawy A
Life Sci. 2022; 309:121048.
PMID: 36209833
PMC: 9536875.
DOI: 10.1016/j.lfs.2022.121048.